The Cancer Forum invites abstracts for oral presentations, symposia, and posters describing original research and innovative intervention programs or policies that address topics including behavioral, genetic, socioeconomic, and environmental risk factors for cancer; prevention and early detection; cancer treatment access and outcomes; clinical trials; cancer disparities; cancer literacy and cancer communication; and cancer survivorship.

Special consideration will be given to research pertaining to this year’s conference theme, “Creating the Healthiest Nation: For science. For action. For health.” as well as topics relevant to forums/special interest groups with whom the Cancer Forum has a history of hosting joint/collaborative sessions (e.g. Alcohol and Tobacco Use, Epidemiology, Global/International Health, Mens Health Caucus, Womens Caucus).  Other potential topics that are relevant to the conference theme and/or the broader mission of the Cancer Forum include:

• Cancer Clinical Care and Survivorship
  Advancing Clinical Care and Treatment for cancer and associated complications (e.g. clinical trials examining cancer therapeutics, advancements in precision medicine)

  Developing and promoting Cancer Survivorship resources for patients and caregivers (e.g. evaluation of social and instrumental support in long-term outcomes, interventions designed to improve quality of life for survivors and caregivers.

• Cancer Prevention
  Enhancing Cancer Prevention efforts (e.g. identification of environmental or behavioral risk factors, early interventions targeting risk factors/behaviors such as tobacco use)
• Cancer Screening/Diagnosis
  Improving Cancer Screening/Diagnosis (e.g. evaluation of community outreach programs to increase screening rates, technological advancement to improve diagnosis and care)
• Health Disparities
  Eliminating Health Disparities across the cancer care continuum (e.g. interventions addressing barriers to care, identification of at-risk subpopulations)
• Laws, Guidelines and Policies
  Evaluating Laws, Guidelines, and Policies that reduce the public health burden of cancer (e.g. improving access/affordability to screening and treatment, tobacco control regulations, controversies in treatment and prevention guidelines)

Submitted abstracts will be evaluated based on their conceptual and methodological quality, innovation and novelty, and relevance to the conference theme. Abstracts submitted to the Cancer Forum are required to include quantitative or qualitative data to be considered for acceptance. Preliminary or pilot data are acceptable, but proposed projects or abstracts with no data at all to report at the time of the abstract deadline will be rejected.

Abstracts are limited to 250 words or less.

Referral to web pages or URLs may not be used for abstracts.

An author may not submit the same abstract to more than one Section, SPIG, Caucus or Forum.

Preferences for oral versus poster presentation will be considered, but the program committee will consider all abstracts for both oral and poster categories. Oral presentations at contributed sessions are generally 13-15 minutes in length. An additional 3-5 minutes will be available for discussion and questions from the audience. Presenters at poster sessions should display their work and be available to answer questions throughout the scheduled 60 minute poster session.

If you are interested in submitting a panel/symposium for consideration as part of the 2019 APHA Cancer Forum program, please contact the Program Planners (contact info below) for additional instructions. For any and all inquiries about your abstract, always refer to the abstract number assigned to you by the online system.

Continuing Education Credit

APHA values the ability to provide continuing education credit to physicians, nurses, health educators, veterinarians, and those certified in public health at its annual meeting. Please complete all required information when submitting an abstract so members can claim credit for attending your session. These credits are necessary for members to keep their licenses and credentials.

For a session to be eligible for Continuing Education Credit, each presenter must provide:

• An abstract free of trade and/or commercial product names
• At least one MEASURABLE outcomes (DO NOT USE “To understand” or “To learn” as objectives, they are not measureable). Examples of Acceptable Measurable Action Words:  Explain, Demonstrate, Analyze, Formulate, Discuss, Compare, Differentiate, Describe, Name, Assess, Evaluate, Identify, Design, Define or List.
• A signed Conflict of Interest (Disclosure) form with a relevant Qualification Statement. See an example of an acceptable Qualification Statement on the online Disclosure form.

Contact Mighty Fine at mighty.fine@apha.org if you have any questions concerning continuing education credit. Please contact the program planners (listed below) for all other questions.

---

Ready?

Program Planner Contact Information:

Michael Halpern, MD, PhD, MPH
Department of Health Services Administration and Policy
Temple University College of Public Health
1301 Cecil B. Moore Ave.
Ritter Annex #533
Philadelphia, PA 19122
Phone: 215-204-5814
Fax: 215-204-5958
michael.halpern@temple.edu

and
Adriana Babiak-Vazquez, PhD, MPH, CM
Epidemiology
KBRwyle at NASA Johnson Space Center
2400 NASA Parkway
Houston, TX 77058
Phone: 281-483-9705
adriana.e.babiak-vazquez@nasa.gov

and
Jennifer Ersek, PhD
Solid Tumor Oncology
Levine Cancer Institute
University of North Carolina at Charlotte, Atrium Health- Carolinas HealthCare System
10620 Park Road, Suite 112, Office 119
Charlotte, NC 28210
Phone: 704-654-0884
jennifer.ersek@atriumhealth.org